Previous studies revealed that 6-shogaol ameliorated diabetic nephropathy in db/db mice partly through its anti-inflammatory action by decreasing the TNF-α, monocyte chemotactic protein-1 (MCP-1), and IL-6 levels in the circulation and kidneys while suppressing NF-κB expression [40]. This evidence concerns the gene CCL2 and diabetic kidney disease.